Surgical Outcomes of CheckMate816 Support Use of Neoadjuvant Nivolumab Plus Chemotherapy for NSCLC

VIOLET Data Establishes VATS as Standard for Early-Stage Resectable NSCLC

First Comprehensive Genomic Profiling Assay Approved for Use with Brigatinib, ALK-positive NSCLC

High-Dose Once-Daily Thoracic Radiotherapy Did Not Improve OS in Limited Stage SCLC

Single Institution’s Experience: SABR Shows Outstanding OS vs. VATS in Patients with Early-Stage NSCLC

IMpower010: Adjuvant Atezolizumab Improved DFS in PD-L1 Expressing Stage II-IIIA NSCLC

Selpercatinib Approved in Canada for Metastatic NSCLC with RET Fusions

Sotorasib Wins Approval for Unmet Need in KRAS G12C-Driven NSCLC

Leveraging Lung Cancer Screening Scans to Detect Early Interstitial and Obstructive Lung Disease

Low-Dose CT Screening with Guidance from Biomarkers May be Beneficial for Some Patients Who Have Never Smoked

Strategies for Implementing Lung Cancer Screening Programs in Low-Middle Income Countries

Low-Dose CT Could be One-Stop Test for Early Signs of China’s ‘Big Three’ Chest Diseases